Correlation Between a Novel Subset of Neutrophil and Corneal Neovascularization.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

66 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-01

Study Completion Date

2023-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether a novel subset of neutrophils is correlated with corneal neovascularization in the patients suffered from ocular chemical injury.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Association Between Autoimmune or Inflammation and Thyroid Disease

NCT02886949

THYROTOXICOSIS

UNKNOWN

A Disease Area Study on the Awareness and Perceptions of Systemic Inflammation and hsCRP as a biomARKer in Patients With ASCVD and CKD in China Among Cardiologists and Nephrologists

NCT06589791

Atherosclerotic Cardiovascular Disease (ASCVD) Chronic Kidney Disease (CKD)

COMPLETED

Research on the Application and Mechanism of New Biological Probes in Biomedicine

NCT04977739

Tumors Cardiovascular Diseases Respiratory System Diseases +8 more

COMPLETED

Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies

NCT00995891

Healthy Volunteers

COMPLETED

Acute and Chronic Inflammatory Disease, Lifestyle and Treatment Response

NCT04193020

Uveitis

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cornea is an avascular transparent tissue providing refractive power for suitable optical performance. But under the condition of injury or infection, the stable microenvironment of ocular surface has been destroyed. Vessels sprout from the limbus to form corneal neovascularization, becoming an important pathological feature and leading cause of blindness. However, the underlying mechanism particular the inflammation-mediated mechanism remains unclear.

With the advancement of single-cell RNA sequencing (scRNA-seq), the investigation of immune cell transcriptomes has obtained great process . Using this advanced method, we identified different immune cell types in the ocular surface microenvironment in corneal neovascularization mouse model. Particularly, we found a specific subset of neutrophils played important role during the corneal angiogenesis. Using the loss-of-function and gain-of-function experiment, we clarified that this novel subset of neutrophils is the major factor that promoting corneal angiogenesis in mouse model. To further explore the relationship between this subset of neutrophils and angiogenesis in human, we plan to detect whether the neutrophil subset is increased in the circulation of chemical burned corneal neovascularization patients.

The main purpose of this study is to assess whether the novel subset of neutrophils has correlation with chemical burned corneal neovascularization. Approximately 33 patients and 33 age matched healthy controls will be recruited. The clinical characteristics, 4ml peripheral blood and the images of slit lamp photography will be obtained.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Corneal Neovascularization Neutrophils

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy people

Healthy participants whose age and gender are consistent with CNV patients

No interventions assigned to this group

CNV patients

Patients who are diagnosed ocular chemical injury coming to Zhongshan Eye Center, Sun Yat-sen University for medical care

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Diagnosed ocular chemical injury with or without corneal neovascularization.

Exclusion Criteria

1. Those who are diagnosed ocular diseases except for chemical ocular injury, such as uveitis, retinopathy.
2. Those who are diagnosed allergic disease, autoimmune diseases or hematological diseases, infectious disease, such as eczema, systemic lupus erythematosus (SLE), agranulocytosis and viral hepatitis.
3. Those who took immunosuppressive treatments in the past 3 months.
4. Pregnant or nursing women.
5. Those who have serious heart, lung, liver or kidney diseases.
6. Those who have serious systemic diseases.
7. Those who performed ocular surgery (including cataract surgery) in recent three months.
8. Those who have been enrolled in other interventional clinical studies at the same time.
9. Those who are unable to complete the study according to the investigators' requirements.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes